Connection

James Chappell to Middle East Respiratory Syndrome Coronavirus

Back to Details
This is a "connection" page, showing publications James Chappell has written about Middle East Respiratory Syndrome Coronavirus.
James Chappell
Connection Strength
0.180
Middle East Respiratory Syndrome Coronavirus
  1. Small-Molecule Antiviral ß-d-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance. J Virol. 2019 12 15; 93(24).
    View in: PubMed
    Score: 0.043
  2. Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD. Cell Rep. 2019 09 24; 28(13):3395-3405.e6.
    View in: PubMed
    Score: 0.043
  3. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape. J Virol. 2018 05 15; 92(10).
    View in: PubMed
    Score: 0.039
  4. Middle East Respiratory Syndrome. N Engl J Med. 2017 02 09; 376(6):584-594.
    View in: PubMed
    Score: 0.035
  5. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020 04 29; 12(541).
    View in: PubMed
    Score: 0.011
  6. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A. 2017 08 29; 114(35):E7348-E7357.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.